2020
DOI: 10.1016/j.regg.2019.11.003
|View full text |Cite
|
Sign up to set email alerts
|

Vasculitis leucocitoclástica inducida por cotrimoxazol

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 3 publications
0
1
0
Order By: Relevance
“…6,8 A review of existing literature revealed 3 previously reported cases of an association between trimethoprimsulfamethoxazole and leukocytoclastic vasculitis, of which one had underlying ANCA-positive vasculitis, whereas no other underlying condition was found in the other 2 cases. [9][10][11] Our patient developed mixed cryoglobulinemia (type 2) that was triggered by exposure to trimethoprim-sulfamethoxazole, and the complete investigative workup for type II cryoglobulinemia was unremarkable. Our patient had only cutaneous manifestation presenting as leukocytoclastic vasculitis without systemic involvement.…”
Section: Trimethoprim-sulfamethoxazole-induced Type 2 Cryoglobulinemi...mentioning
confidence: 99%
“…6,8 A review of existing literature revealed 3 previously reported cases of an association between trimethoprimsulfamethoxazole and leukocytoclastic vasculitis, of which one had underlying ANCA-positive vasculitis, whereas no other underlying condition was found in the other 2 cases. [9][10][11] Our patient developed mixed cryoglobulinemia (type 2) that was triggered by exposure to trimethoprim-sulfamethoxazole, and the complete investigative workup for type II cryoglobulinemia was unremarkable. Our patient had only cutaneous manifestation presenting as leukocytoclastic vasculitis without systemic involvement.…”
Section: Trimethoprim-sulfamethoxazole-induced Type 2 Cryoglobulinemi...mentioning
confidence: 99%